CAS 2283355-59-7

MKK7-COV-9

CAS: 2283355-59-7

MKK7-COV-9

Purity: ≥98%

Molecular weight: 320.35g/mol

Ref: 54-BUP13093

MKK7-COV-9

CAS: 2283355-59-7

MKK7-COV-9 is a potent inhibitor of kinases that plays a critical role in apoptosis, also known as programmed cell death. It has been extensively studied in Chinese and human tumor cells and has been shown to be an effective anticancer agent. MKK7-COV-9 is an analog of the cyclin-dependent kinase (CDK) inhibitors and has been found to inhibit the growth of cancer cells by blocking the activity of CDKs. This protein kinase inhibitor has also been found in urine samples from cancer patients, suggesting its potential as a biomarker for cancer diagnosis and treatment. The inhibitory effect of MKK7-COV-9 on tumor cell proliferation makes it a promising candidate for developing novel anticancer drugs.

Formula: C₁₈H₁₆N₄O₂

Purity: Min. 95%

Molecular weight: 320.3 g/mol

Ref: 3D-IRD35559

MKK7-COV-9

CAS: 2283355-59-7

MKK7-COV-9 is an MKK7 inhibitor that inhibits MKK7-induced protein-protein interactions and interrupts the activation of primary B cells in response to LPS.

Formula: C₁₈H₁₆N₄O₂

Purity: 99.07% - 99.73%

Color and Shape: Solid

Molecular weight: 320.35

Ref: TM-T60857